News
10d
Zacks Investment Research on MSNCME Gains 11% YTD: Time to Buy the Stock at a P/E of 23.82X?Shares of CME Group CME have gained 10.7% year to date, outperforming the industry, the sector and the Zacks S&P 500 ...
In this update, I will therefore revisit the CME investment case ... 2024 was another very successful year for the CME Group. Firstly, CME Group beat estimates on both earnings and revenue.
Technology Investment: Ongoing investments in technology aim ... which could provide future growth opportunities. While CME Group has long been a dominant player in the derivatives market, the ...
CME Group (NASDAQ:CME – Free Report) had its target price increased by Barclays from $263.00 to $279.00 in a research note ...
CHICAGO, April 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives ... ADV of 9.7 million contracts and double-digit ADV growth in interest rate, energy, agricultural, foreign ...
CME Group (CME) announced that its quarterly international average daily volume reached a record 8.8M contracts in Q1 2025, up 19% year on ...
CME GROUP INC (CME) is a large-cap growth stock in the Investment Services industry. The rating using this strategy is 87% based on the firm’s underlying fundamentals and the stock’s valuation.
Revenue Growth: CME Group's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 5.98%. This indicates ...
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results